Andrea Necchi gives us the lowdown of efficacy and toxicity of this combination.

Episode 325 ASCO24: KN426 and the CLEAR trial - tissue based biomarkers for kidney cancer

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London